317 related articles for article (PubMed ID: 23396213)
21. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
Cronin DM; George TI; Reichard KK; Sundram UN
Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
[TBL] [Abstract][Full Text] [Related]
22. Atypical presentation of blastic plasmacytoid dendritic cell neoplasm: A potential diagnostic pitfall in nasal cavity.
Yu F; Sun K; Wang Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Oct; 126(4):e212-e214. PubMed ID: 29884520
[TBL] [Abstract][Full Text] [Related]
23. Blastic plasmacytoid dendritic cell neoplasm: report of two pediatric cases.
Dharmani PA; Mittal NM; Subramanian PG; Galani K; Badrinath Y; Amare P; Gujral S
Indian J Pathol Microbiol; 2015; 58(1):72-6. PubMed ID: 25673598
[TBL] [Abstract][Full Text] [Related]
24. The advances in therapy of blastic plasmacytoid dendritic cell neoplasm.
Kerr D; Sokol L
Expert Opin Investig Drugs; 2018 Sep; 27(9):733-739. PubMed ID: 30118336
[TBL] [Abstract][Full Text] [Related]
25. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
[TBL] [Abstract][Full Text] [Related]
26. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.
Jegalian AG; Buxbaum NP; Facchetti F; Raffeld M; Pittaluga S; Wayne AS; Jaffe ES
Haematologica; 2010 Nov; 95(11):1873-9. PubMed ID: 20663945
[TBL] [Abstract][Full Text] [Related]
27. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity.
Qayoom S; Durga G; George S; Rahman K
Indian J Pathol Microbiol; 2015; 58(3):377-80. PubMed ID: 26275271
[TBL] [Abstract][Full Text] [Related]
28. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
29. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
[TBL] [Abstract][Full Text] [Related]
30. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
31. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy.
Deotare U; Yee KW; Le LW; Porwit A; Tierens A; Musani R; Barth D; Torlakovic E; Schimmer A; Schuh AC; Seftel M; Minden MD; Gupta V; Hyjek E
Am J Hematol; 2016 Mar; 91(3):283-6. PubMed ID: 26619305
[TBL] [Abstract][Full Text] [Related]
32. [Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms].
Löffler H; Kosely F; Ho AD; Krämer A
Dtsch Med Wochenschr; 2009 Sep; 134(39):1927-30. PubMed ID: 19760552
[TBL] [Abstract][Full Text] [Related]
33. Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects.
Trottier AM; Cerquozzi S; Owen CJ
Blood Lymphat Cancer; 2017; 7():85-93. PubMed ID: 31360087
[TBL] [Abstract][Full Text] [Related]
34. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
[TBL] [Abstract][Full Text] [Related]
35. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract][Full Text] [Related]
36. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
37. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
Zheng G; Schmieg J; Guan H; Ali SZ
Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kharfan-Dabaja MA; Cherry M
Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425
[TBL] [Abstract][Full Text] [Related]
39. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kerr D; Zhang L; Sokol L
Curr Treat Options Oncol; 2019 Feb; 20(1):9. PubMed ID: 30715612
[TBL] [Abstract][Full Text] [Related]
40. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
